SG11201909977PA - Characteristic metabolites in miscarriages - Google Patents
Characteristic metabolites in miscarriagesInfo
- Publication number
- SG11201909977PA SG11201909977PA SG11201909977PA SG11201909977PA SG 11201909977P A SG11201909977P A SG 11201909977PA SG 11201909977P A SG11201909977P A SG 11201909977PA SG 11201909977P A SG11201909977P A SG 11201909977PA
- Authority
- SG
- Singapore
- Prior art keywords
- singapore
- international
- nanyang
- pte
- tan
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/493—Physical analysis of biological material of liquid biological material urine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 01 November 2018 (01.11.2018) WIPO I PCT mu °million °nolo mooloin moilmioluo oimIE (10) International Publication Number WO 2018/199849 Al (51) International Patent Classification: GO1N 33/74 (2006.01) GO1N 33/493 (2006.01) (21) International Application Number: PCT/SG2018/050208 (22) International Filing Date: 30 April 2018 (30.04.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 10201703502T 28 April 2017 (28.04.2017) SG (71) Applicants: SINGAPORE HEALTH SERVICES PTE. LTD. [SG/SG]; 31 Third Hospital Avenue, #03-03, Bowyer Block C, Singapore 168753 (SG). NANYANG TECH- NOLOGICAL UNIVERSITY [SG/SG]; 50 Nanyang Av- enue, Singapore 639798 (SG). (72) Inventors: TAN, Thiam Chye; c/o KK Women's and Children's Hospital Pte. Ltd., 100 Bukit Timah Road, Sin- gapore 229899 (SG). KU, Chee Wai; c/o KK Women's and Children's Hospital Pte. Ltd., 100 Bukit Timah Road, Singapore 229899 (SG). TAN, Nguan Soon; c/o Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798 (SG). TAN, Zhen Wei; c/o Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798 (SG). (74) Agent: SPRUSON & FERGUSON (ASIA) PTE LTD; P.O. Box 1531, Robinson Road Post Office, Singapore 903031 (SG). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: — of inventorship (Rule 4.17(iv)) Published: — with international search report (Art. 21(3)) in black and white; the international application as filed contained color or greyscale and is available for download from PATENTSCOPE (54) Title: CHARACTERISTIC METABOLITES IN MISCARRIAGES (57) : Disclosed herein are methods of identifying the risk of a miscarriage in a subject comprising detecting and measuring the concentration of at least one metabolite in a sample obtained from the subject. Specifically, an increase in concentration of tetrahy- drocortisone, and a decrease in concentration of propionylcarnitine, isovalerylcarnitine, 3- methylglutarylcarnitine, hexanoylcarnitine or 3a,20a-dihydroxy-5[3-pregnane-3-glucuronide in a serum or a urine sample are associated with spontaneous miscarriage in first trimester pregnancy. Also disclosed herein are kits for determining the risk of a miscarriage in a subject.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG10201703502T | 2017-04-28 | ||
PCT/SG2018/050208 WO2018199849A1 (en) | 2017-04-28 | 2018-04-30 | Characteristic metabolites in miscarriages |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201909977PA true SG11201909977PA (en) | 2019-11-28 |
Family
ID=63917738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201909977P SG11201909977PA (en) | 2017-04-28 | 2018-04-30 | Characteristic metabolites in miscarriages |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN110785664A (en) |
SG (1) | SG11201909977PA (en) |
WO (1) | WO2018199849A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5786220A (en) * | 1995-04-28 | 1998-07-28 | Quidel Corporation | Assays and devices for distinguishing between normal and abnormal pregnancy |
US20140221236A1 (en) * | 2013-02-01 | 2014-08-07 | Kristi S. Borowski | Metabolomic markers for preterm birth |
US20150090010A1 (en) * | 2013-09-27 | 2015-04-02 | Chang Gung University | Method for diagnosing heart failure |
GB201317458D0 (en) * | 2013-10-02 | 2013-11-13 | Spd Swiss Prec Diagnostics Gmbh | Improved pregnancy test device and method |
-
2018
- 2018-04-30 SG SG11201909977P patent/SG11201909977PA/en unknown
- 2018-04-30 WO PCT/SG2018/050208 patent/WO2018199849A1/en active Application Filing
- 2018-04-30 CN CN201880042548.9A patent/CN110785664A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN110785664A (en) | 2020-02-11 |
WO2018199849A1 (en) | 2018-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201809294RA (en) | Systems and methods for sensor data analysis through machine learning | |
SG11201804506RA (en) | Systems and methods for rendering multiple levels of detail | |
SG11201803666WA (en) | Single image detection | |
SG11201804943VA (en) | Autonomous vehicle services | |
SG11201407668XA (en) | Method and device for detecting an analyte in a body fluid | |
SG11201809913PA (en) | Methods for detecting target nucleic acids in a sample | |
SG11201811740WA (en) | Systems and methods for identifying risky driving behavior | |
SG11201408385TA (en) | Methods of detecting diseases or conditions | |
SG11201900116RA (en) | Communication flow for verification and identification check | |
SG11201806806YA (en) | System and method for processing simultaneous carpool requests | |
SG11201903958SA (en) | Intuitive occluded object indicator | |
SG11201808494TA (en) | Signal light detection | |
SG11201811343SA (en) | System and methods for detecting online fraud | |
SG11201810694WA (en) | Use of biomarkers in determining susceptibility to disease treatment | |
SG11201807307VA (en) | System and method for aerial system discrimination and action | |
SG11201901834WA (en) | Micrornas as biomarkers for endometriosis | |
SG11201908767QA (en) | Method for accurate diagnosis of a disease targeting biomarkers in liquid biopsy | |
SG11201407788TA (en) | Queue management system and method | |
SG11201811691RA (en) | Systems and methods for verifying authenticity of id photo | |
SG11201407660SA (en) | Systems and methods for detection of particles in a beneficial agent | |
SG11201908865WA (en) | Apparatus and method for absolute quantification of biomarkers for solid tumor diagnosis | |
SG11201811690TA (en) | Systems and methods for cheat examination | |
SG11201806401YA (en) | G protein-coupled receptor (gpcr) modulation by imipridones | |
SG11201808302VA (en) | Methods and systems for determining a drop delay of a flow stream in a flow cytometer | |
SG11201408383SA (en) | Methods of detecting diseases or conditions using circulating diseased cells |